Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Brain scans of people who are in love look similar to scans of drug addicts.
Contrast MRI may lead to better diagnosis for bladder pain syndrome
Scientists are developing at new ways to specifically target tumors.
Researcher reveals innovative approach for diagnosing interstitial cystitis.